Exalenz Biosciences BreathID(R) Hp and BreathID Hp Lab Systems Receive FDA Clearance for Diagnosis of Helicobacter pylori Testing in Pediatric Patients
Important new testing option for an infection that impacts nearly 20 million U.S. children and may have significant negative impacts on long-term health
MODI'IN, Israel and MANASQUAN, N.J., March 13, 2018 -- (Healthcare Sales & Marketing Network) -- Exa... Diagnostics, FDA Exalenz Bioscience, BreathID, Helicobacter pylori, H. pylori (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 13, 2018 Category: Pharmaceuticals Source Type: news
The Proven & Unproven Health Benefits Of Honey
By Sandee LaMotte, CNN
(CNN) — Move over, prehistoric bears. Humans have loved honey since the Stone Age.
Rock art pictures of honey harvesting, which at first glance look like drawings from A.A. Milne’s Winnie-the-Pooh, date to about 8000 B.C.
Beeswax has been found on pottery dating as far back as 7000 B.C., most likely used for waterproofing. The ancient Egyptians offered honey to the gods and then joined the Greeks, Romans and Chinese in using it as a salve for wounds and a treatment for fevers and stomach ailments.
Today, proponents of honey tout its miraculous healing properties, claiming that it can prev...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 20, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Honey Source Type: news
< i > H. pylori < /i > ( < i > Helicobacter Pylori < /i > ) Infection Symptoms, Test, Treatment
Title:H. pylori (Helicobacter Pylori ) Infection Symptoms, Test, TreatmentCategory: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 1/9/2018 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - January 9, 2018 Category: Nutrition Source Type: news
H. Pylori Eludes Immune Response Via Cholesterol Depletion H. Pylori Eludes Immune Response Via Cholesterol Depletion
Manipulation of cell cholesterol levels allows Helicobacter pylori to escape full elimination by host immunity, according to German researchers.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 2, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news
Illusions Regarding H. pylori Trials and Treatment Guidelines Illusions Regarding H. pylori Trials and Treatment Guidelines
In this commentary, the author points out major flaws in treatment studies and meta-analyses pertaining to H. pylori eradication therapy. Are we overlooking the most important detail?Gut (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 14, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
Gastric cancer: A new strategy used by Helicobacter pylori to target mitochondria
(Institut Pasteur) Scientists from the Institut Pasteur and CNRS have recently identified new strategies used by Helicobacter pylori bacteria to infect cells. By specifically targeting mitochondria these bacteria, despite being extracellular, can optimize infection in the host. These findings pave the way for new strategies to combat H. pylori infection, which is associated with most cases of gastric cancer and several other gastric disorders. The results were published on Nov. 21 in the journal Scientific Reports. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 28, 2017 Category: Cancer & Oncology Source Type: news
The Global Recurrence Rate of Helicobacter Pylori The Global Recurrence Rate of Helicobacter Pylori
Is the recurrence rate following H. pylori eradication therapy associated with socioeconomic and sanitary conditions?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 24, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
Shape-shifting agent targets harmful bacteria in the stomach
(University of Illinois at Urbana-Champaign) A new shape-shifting polymer can target and kill Helicobacter pylori bacteria in the stomach without killing helpful bacteria in the gut. Such a treatment could improve the digestive health of billions of people worldwide who contract H. pylori infections. The antimicrobial agent morphs into a bacterial hole-puncher in the stomach's acidic environment and reverts to an amorphous, inactive structure when it reaches the higher pH environment of the small intestine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 14, 2017 Category: International Medicine & Public Health Source Type: news
How Helicobacter pylori causes gastric cancer
(University of Erlangen-Nuremberg) Gastric cancer is one of the five most fatal types of cancer. According to the statistics of the World Health Organization about 750,000 patients die each year after developing the disease. The main cause is thought to be the bacterium Helicobacter pylori. Researchers at Friedrich-Alexander-Universit ä t Erlangen-N ü rnberg (FAU) have now identified two mechanisms through which this bacterium can cause gastric cancer. Their findings could result in the development of new therapeutic approaches. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 7, 2017 Category: Cancer & Oncology Source Type: news
Acid reflux drugs linked to increased stomach cancer risk
Conclusion
PPIs are commonly used medicines for acid reflux. This may seem like alarming news for the many people in the UK who take them, but it's important to remember that the overall risk of stomach cancer is still very low.
This study has several limitations that mean we should be cautious about the results:
This type of study can't prove PPIs caused the increased risk of cancer. The increased risk could be down to other factors.
Researchers were unable to adjust their figures to take account of some relevant confounding factors, such as alcohol and tobacco use, as these weren't routinely recorded.
Almost all the pati...
Source: NHS News Feed - November 1, 2017 Category: Consumer Health News Tags: Cancer Source Type: news
PPI Use After H. pylori Eradication Therapy Tied to Increased Risk for Gastric Cancer (FREE)
By Amy Orciari Herman
Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM
Long-term use of proton-pump inhibitors (PPIs) after treatment for Helicobacter pylori infection is associated with increased risk for gastric cancer, according to a … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - November 1, 2017 Category: Primary Care Source Type: news
Long-term use of PPIs linked to doubling in stomach cancer risk
Risk rose with dose and duration of treatment after H pylori eradication Related items fromOnMedica Proton pump inhibitors associated with raised mortality Oesophageal and stomach cancer linked to early adulthood overweight Experts link alcohol to stomach cancer (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 1, 2017 Category: UK Health Source Type: news
Heartburn Drugs Tied to Stomach Cancer Risk
After treatment for H. pylori infection, people who took proton pump inhibitors were at increased risk of stomach cancer. (Source: NYT Health)
Source: NYT Health - October 31, 2017 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Stomach Cancer Ulcers Heartburn Bacteria Helicobacter Pylori (Bacterium) Source Type: news
Gastric Cancer Risk Doubled With Long-term PPI Use Gastric Cancer Risk Doubled With Long-term PPI Use
The risk for gastric cancer increases with the dose and duration of proton-pump inhibitor use after successful H pylori eradication.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 31, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Long-term PPI Use Tied to Doubled Risk for Gastric Cancer Long-term PPI Use Tied to Doubled Risk for Gastric Cancer
The risk for gastric cancer increases with the dose and duration of proton-pump inhibitor use after successful H pylori eradication.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 31, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
